ETC
IMRX icon

Exchange Traded Concepts’s Immuneering IMRX Stock Holding History

Exchange Traded Concepts’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-58,349
Closed -$128K – 1350
2024
Q4 		$128K Hold
58,349
– – ﹤0.01% 1099
2024
Q3 		$145K Sell
58,349
-16,590
-22% -$24.1K ﹤0.01% 1076
2024
Q2 		$95.9K Sell
74,939
-23,315
-24% -$38.3K ﹤0.01% 941
2024
Q1 		$284K Buy
98,254
+80,838
+464% +$453K 0.01% 826
2023
Q4 		$128K Buy
17,416
+4,417
+34% +$29.4K ﹤0.01% 854
2023
Q3 		$99.8K Sell
12,999
-1,885
-13% -$17.3K ﹤0.01% 896
2023
Q2 		$151K Buy
+14,884
New +$143K ﹤0.01% 841

Other funds holding IMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Exchange Traded Concepts's IMRX Position: Q1 2025 in Review

Exchange Traded Concepts sold out of Immuneering (IMRX) in Q1 2025, closing a stake of 58,349 shares — an estimated $128K sold.

Exchange Traded Concepts first reported a position in IMRX in Q2 2023 and held it in 7 quarters. The position peaked at $284K in Q1 2024. 35 funds tracked by Wall St. Rank hold IMRX as of Q1 2025.

  • Exchange Traded Concepts reported no remaining Immuneering position as of Q1 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 58,349 Immuneering shares in Q1 2025, an estimated $128K.
  • Exchange Traded Concepts first reported a position in Immuneering in Q2 2023 and held it in 7 quarters.
  • Exchange Traded Concepts's Immuneering position peaked at $284K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Immuneering as of Q1 2025.

Based on Exchange Traded Concepts's 13F filing for Q1 2025, filed 17 Apr 2025.